FDA Drug Application (203612) for FLUDEOXYGLUCOSE F18 by MCPRF

Back to FDA Applications sponsored by MCPRF

Application Number203612
Product Number001
FormINJECTABLE;INTRAVENOUS
Dosage20-240mCi/ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameFLUDEOXYGLUCOSE F18
Active IngredientFLUDEOXYGLUCOSE F-18



Back to FDA Applications sponsored by MCPRF